Oleamide potentiates benzodiazepine-sensitive γ-aminobutyric acid receptor activity but does not alter minimum alveolar anesthetic concentration

Anesthesia and Analgesia

Volumn 86, Issue 6, 1998, Pages 1294-1300

  Yost, C Spencer ^a,b   Hampson, Aidan J ^b,d   Leonoudakis, Dmitri ^a   Koblin, Donald D ^a,c   Bornheim, Lester M ^b   Gray, Andrew T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; DESFLURANE; LIPID; OLEAMIDE; UNCLASSIFIED DRUG;

ANESTHESIA INDUCTION; ANESTHESIA MECHANISM; ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM DEPRESSION; CHLORIDE CURRENT; DRUG POTENTIATION; DRUG RECEPTOR BINDING; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; RAT; XENOPUS LAEVIS;

ANESTHETICS, INHALATION; ANIMALS; BENZODIAZEPINES; CEREBROSIDES; CHLORIDE CHANNELS; DRUG SYNERGISM; INJECTIONS, INTRAPERITONEAL; ION CHANNEL GATING; ION CHANNELS; ISOFLURANE; MOVEMENT; OLEIC ACID; OLEIC ACIDS; OOCYTES; PAIN; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SEROTONIN; SLEEP; XENOPUS LAEVIS;

EID: 0031811635     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199806000-00031     Document Type: Article

References (24)

1. Zoltoski RK, Fenwick P. The neurochemistry of sleep. In: Cooper R, ed. Sleep. London: Chapman & Hall Medical, 1994: 135-74.
2. Zhdanova IV, Wurtman RJ, Lynch HJ, et al. Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 1995;57:552-8.
3. Cravatt BF, Prospero-Garcia O, Siuzdak G, et al. Chemical characterization of a family of brain lipids that induce sleep. Science 1995;268:1506-9.
4. Cravatt BF, Giang DK, Mayfield SP, et al. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 1996;384:83-7.
5. A receptor shows a ligand-gated receptor super-family. Nature 1987;328:221-7.
6. Nicoll RA, Malenka RC, Kauer JA. Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system. Physiol Rev 1990;70:513-26.
7. A receptor subunit for benzodiazepine pharmacology. Nature 1989;338:582-5.
8. A-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol 1995;359:154-94.
9. Huidobro-Toro JP, Harris RA. Brain lipids that induce sleep are novel modulators of 5-hydroxytryptamine receptors. Proc Natl Acad Sci USA 1996;93:8078-82.
10. Quick MW, Lester HA. Methods for expression of excitability proteins in Xenopus oocytes. In: Conn PM, ed. Methods in neuroscience. Vol. 19. San Diego, CA: Academic, 1994:261-79.
11. Eger EI II, Johnson BH. MAC of 1-653 in rats, including a test of the effect of body temperature and anesthetic duration. Anesth Analg 1987;66:974-6.
12. Mechoulam R, Fride E, Hanus L, et al. Anandamide may mediate sleep induction. Nature 1997;389:25-6.
13. Witt M-R, Nielsen M. Characterization of the influence of unsaturated free fatty acids on brain GABA/benzodiazepine receptor binding in vitro. J Neurochem 1994;62:1432-9.
14. 1c receptors in rat brain. J Pharmacol Exp Ther 1990;255:843-57.
15. Khrestchatisky M, MacLennan AJ, Chiang MY, et al. A novel alpha subunit in rat brain GABAA receptors. Neuron 1989;3: 745-53.
16. Melvin MA, Johnson BH, Quasha AL, Eger EI II. Induction of anesthesia with midazolam decreases halothane MAC in humans. Anesthesiology 1982;57:238-41.
17. Greiner AS, Larach DR. The effect of benzodiazepine receptor antagonism by flumazenil on the MAC of halothane in the rat. Anesthesiology 1989;70:644-8.
18. Rampil IJ, Mason P, Singh H. Anesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiology 1993;78:707-12.
19. Rampil IJ. Anesthetic potency is not altered after hypothermic spinal cord transection in rats. Anesthesiology 1994;80:606-10.
20. Willow M, Johnston GA. Dual action of pentobarbitone on GABA binding: role of binding site integrity. J Neurochem 1981;37:1291-4.
21. Whiting P, McKernan RM, Iversen LL. Another mechanism for creating diversity in gamma-aminobutyrate type A receptors: RNA splicing directs expression of two forms of gamma 2 phosphorylation site. Proc Natl Acad Sci USA 1990;87:9966-70.
22. Wafford KA, Burnett DM, Leidenheimer NJ, et al. Ethanol sensitivity of the GABAA receptor expressed in Xenopus oocytes requires 8 amino acids contained in the gamma 2L subunit. Neuron 1991;7:27-33.
23. A receptor function and ethanol. FEBS Lett 1993;324:140-2.
24. A/benzodiazepine receptor heterogeneity: neurophysiological implications. Neuropharmacology 1995;34:245-54.